Onesource said Orbicular Pharma with its US-based front-end partner have secured the US Food and Drug administration (USFDA) ...

Hyderabad-based Orbicular Pharmaceutical Technologies announced that its generic version of Ozempic (semaglutide injection), developed with Apotex, has received tentative approval from the USFDA. The ...

The approval by the US Food and Drug Administration (USFDA) is for dapagliflozin tablets of strengths 5 mg and 10 mg, Biocon ...

Orbicular receives USFDA tentative approval for generic Semaglutide Injection, partnering with Apotex for U.S.

Alembic Pharmaceuticals secures USFDA approval for generic Methotrexate injection, boosting its oncology portfolio and strengthening its presence in the US generics market.

Apotex Corp. today announced it has received the first U.S. Food and Drug Administration (FDA) Tentative Approval for its Abbreviated New Drug Application (ANDA) for Semaglutide Injection, marking a ...

Future Outlook With ANDA approval secured, Bionpharma will lead the commercialization and distribution of Etravirine tablets in the United States. Both organizations view this achievement as a solid ...

Orbicular Pharma and Apotex receive tentative US FDA approval for generic Ozempic, marking entry into the fast-growing ...

Lupin Limited has received approval from the United States Food and Drug Administration (USFDA) for its Dapagliflozin and ...

This week, PharmTech took a look at the shift toward proactive, data-driven contamination control, the adoption of advanced material science to solve manufacturing hurdles, and an ...

DifGen Pharmaceuticals LLC, a U.S.-based specialty generic pharmaceutical company today announced that its partner, Apotex Inc., has received final approval from the U.S. Food and Drug Administration ...

Partner Apotex Corp. (Apotex) to market and distribute to the U.S. healthcare market ...